Outcome of bronchial artery embolisation for life threatening haemoptysis due to tuberculosis and post tuberculosis sequelae.

医学 支气管动脉 栓塞 外科 肺结核 并发症 肺动脉 动脉 放射科 病理
作者
Anuradha Chandramohan,NK Shyamkumar,Vinu Moses,N R S Surendra Babu,Devasahayam Jesudas Christopher
出处
期刊:Diagnostic and interventional radiology [AVES Publishing Co.]
被引量:29
标识
DOI:10.4261/1305-3825.dir.3876-11.2
摘要

To determine the long-term outcomes of bronchial artery embolization in patients with massive hemoptysis due to pulmonary tuberculosis and post-tuberculosis sequelae and to study the factors influencing success.In this study, 58 patients underwent 64 bronchial artery embolizations for massive hemoptysis due to tuberculosis or its sequelae between 1998 and 2008. Their images and procedure details were reviewed. Medical records and direct contact were used to obtain information on outcome. The cumulative hemoptysis control rate per follow-up interval was calculated.The data showed that 25 patients presented with acute massive hemoptysis and 33 presented with chronic recurrent hemoptysis. The median quantity of blood was 400 mL (range, 70-2000 mL). The median follow-up period was 432 days (range, 11-1789 days). Twenty-seven patients had recurrence after a median period of 110 days after the procedure (range, 1-959 days). The hemoptysis control rate was 93% at 2 weeks, 86% at one month, 79.5% at 3 months, 63% at 6 months, 51% at one year and 39% at 2 years. Six patients underwent repeat procedures. Chest pain was the most common procedure-related complication (n=20, 34.5%); there was no spinal cord complication or mortality. There were seven deaths, five of which were related to hemoptysis. Nine patients were lost to follow-up. Lung cavities (P = 0.08), nonbronchial systemic artery collaterals (P = 0.081) and systemicto- pulmonary venous shunts (P = 0.053) were more common in those who experienced recurrence.Bronchial artery embolization is a relatively safe procedure that is lifesaving in patients who are not suitable for surgery. However, the associated long-term outcome is less satisfactory.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
科研通AI2S应助小绵羊采纳,获得10
1秒前
liuchao完成签到,获得积分10
1秒前
YEFEIeee完成签到 ,获得积分10
1秒前
2秒前
FZUer完成签到,获得积分10
2秒前
JIE完成签到 ,获得积分10
4秒前
任伟超完成签到,获得积分10
4秒前
wws完成签到 ,获得积分10
6秒前
小七完成签到,获得积分10
6秒前
酷小裤完成签到,获得积分10
6秒前
健忘的千凡完成签到,获得积分20
6秒前
李虎完成签到 ,获得积分10
7秒前
ChemistryZyh完成签到,获得积分10
7秒前
没头脑和不高兴完成签到 ,获得积分10
8秒前
飞飞飞发布了新的文献求助10
8秒前
雪落你看不见完成签到,获得积分10
8秒前
酷酷菲音完成签到,获得积分10
9秒前
醉熏的伊完成签到,获得积分10
9秒前
zsh完成签到,获得积分10
9秒前
我是老大应助kaisen采纳,获得30
10秒前
超级行恶完成签到 ,获得积分10
10秒前
健壮的凝冬完成签到 ,获得积分10
10秒前
giao完成签到,获得积分10
11秒前
Darsine完成签到,获得积分10
12秒前
ly完成签到,获得积分10
12秒前
pphss完成签到,获得积分10
12秒前
陈锦鲤完成签到 ,获得积分10
12秒前
gds2021完成签到 ,获得积分10
13秒前
mito完成签到,获得积分10
14秒前
落红禹03发布了新的文献求助20
15秒前
开心夏天完成签到,获得积分10
16秒前
juanlin2011完成签到,获得积分10
16秒前
seattle完成签到,获得积分10
16秒前
压缩完成签到 ,获得积分10
18秒前
xiaohongmao完成签到,获得积分10
18秒前
优雅的帅哥完成签到 ,获得积分10
18秒前
ppppp完成签到,获得积分10
19秒前
20秒前
散步的书包应助66采纳,获得50
21秒前
LiZheng完成签到,获得积分10
22秒前
高分求助中
Evolution 10000
Sustainability in Tides Chemistry 2800
The Young builders of New china : the visit of the delegation of the WFDY to the Chinese People's Republic 1000
юрские динозавры восточного забайкалья 800
English Wealden Fossils 700
叶剑英与华南分局档案史料 500
Foreign Policy of the French Second Empire: A Bibliography 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3146969
求助须知:如何正确求助?哪些是违规求助? 2798221
关于积分的说明 7827159
捐赠科研通 2454808
什么是DOI,文献DOI怎么找? 1306480
科研通“疑难数据库(出版商)”最低求助积分说明 627788
版权声明 601565